Faster protocols also mean less total time exposed to the gastrointestinal side effects that accompany all incretin therapies
Sitagliptin and Metformin Coadministration in Patients with Type 2 Diabetes Inadequately Controlled on Diet and Exercise Table 1 summarizes the most common (5% of patients) adverse reactions reported (regardless of investigator assessment of causality) in a 24-week placebo-controlled factorial study in which sitagliptin and metformin were coadministered to patients with type 2 diabetes inadequately controlled on diet and exercise
Generics, with their affordability factor, will play a crucial role in meeting this demand
In the era of precision prevention, together with updated pooled cohort equations such as the Predicting Risk of Cardiovascular Disease Events (PREVENT) calculator [15, 16] that distinguish the individuals risk of atherosclerotic cardiovascular disease (ASCVD) and/or heart failure (HF), primary preventative strategies could be tailored in accordance to the individuals risk profile [17,18,19]
This article is intended for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment